Quaker Wealth Management’s Zevra Therapeutics ZVRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$235K Buy
21,393
+2,026
+10% +$24K 0.07% 67
2026
Q2
$278K Buy
19,367
+19,167
+9,584% +$213K 0.08% 57
2026
Q1
$1.86K Sell
200
-1,000
-83% -$9.01K ﹤0.01% 433
2025
Q4
$10.8K Buy
+1,200
New +$11.3K ﹤0.01% 295

Other funds holding ZVRA

Quaker Wealth Management's ZVRA Position: Q3 2026 in Review

Quaker Wealth Management increased its Zevra Therapeutics (ZVRA) stake by 10% in Q3 2026, buying an estimated $24K and bringing the position to 21,393 shares worth $235K. The position accounts for 0.07% of the portfolio, ranked #67.

Quaker Wealth Management first reported a position in ZVRA in Q4 2025 and has held it in 4 quarters since. The position peaked at $278K in Q2 2026. 175 funds tracked by Wall St. Rank hold ZVRA as of Q3 2026.

  • Quaker Wealth Management held 21,393 shares of Zevra Therapeutics worth $235K as of Q3 2026.
  • Quaker Wealth Management bought 2,026 Zevra Therapeutics shares in Q3 2026, an estimated $24K.
  • Zevra Therapeutics made up 0.07% of Quaker Wealth Management's portfolio in Q3 2026, its #67 holding.
  • Quaker Wealth Management first reported a position in Zevra Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • Quaker Wealth Management's Zevra Therapeutics position peaked at $278K in Q2 2026.
  • 175 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q3 2026.

Based on Quaker Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.